6OCTOBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comTechnology plays a crucial role in drug development. It is revolutionising clinical trials and decreasing the failure rates. However, the ambiguity around emerging technologies is resulting in slow adoption and fragmented supply. To resolve this, pharma organisations will increasingly adopt AI and big data analytics, in a bid to transform their R&D processes. Disruptive technologies like wearables, mHealth, RWE will pave the way for smaller trials. Patient enrolment, drug administration, and follow-ups will take place through smartphones. Siteless trials through remote applications will also enter the clinical trials space, thus reducing patient enrolment time and increasing diversity of patients and clinical endpoints. Considering all such technological trends entering the sector, organisations will have to equip themselves with the latest clinical trial management solutions to meet the evolving requirements.With significant changes sweeping the pharma industry, there is no doubt that clinical trial management is on the fast track of evolution. Standing at the cusp of clinical trial management technology, there is a wide range of consulting and services companies that are addressing the next generation of clinical trial management needs. To help clients steer through the best-of-breed companies, Pharma Tech Outlook has compiled a list of Top 10 Clinical Trial Management Consulting/Services Companies in Europe 2020.These organisations are transforming the remote work landscape at the cloverleaf of various disruptive technologies and innovative services. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the clinical trial management sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. Let us know your thoughts!Accelerating Drug Development with Advanced TechnologyCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 5 - 2020, Vol 06 - Issue 20 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOKTECH OUTLOOKJaxon JaseMark Christopher
< Page 5 | Page 7 >